Most recent by Kaleb Abbott, OD, MS, FAAO
VIDEO: Vevye offers improved bioavailability, rapid onset, minimal side effects
INDIANAPOLIS — In this Healio video, Kaleb Abbott, OD, MS, FAAO, assistant professor at University of Colorado School of Medicine, discusses three things optometrists should know about Vevye for dry eye.
Prevalence of DED in children slightly lower than adults, but underdiagnosis ‘conceivable’
More research is needed to improve diagnosis of dry eye disease in children, as well as to determine the safety and efficacy of treatment options in this population, according to a literature review published in The Ocular Surface.
Increased monitoring for dementia may be needed in patients with glaucoma
Individuals diagnosed with glaucoma may benefit from increased monitoring for dementia symptoms, particularly if they were diagnosed at age 80 years or older, according to a study in Ophthalmology.
Awareness can reduce challenges associated with preservatives in glaucoma treatment
Eye drops for glaucoma are associated with various adverse effects on the ocular surface that often lead to treatment nonadherence and poor outcomes with surgery, according to a report published in Ocular Surface.